CHILDREN'S NEUROBLASTOMA CANCER FOUNDATION
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$174,963
Cash & Equivalents
94%
Receivables (Non-Related)
4%
Prepaid Expenses
2%
Property, Plant, & Equipment (net)
<1%
Related-Party Receivables
0%
Inventories
0%
Investments
0%
Other Assets
0%
Liabilities in 2024 (Year End)
$6,933
Payables & Accruals
>99%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2023
2024
Change
Cash & Equivalents
$128,588
$164,960
+28%
Receivables (Non-Related)
$6,944
$6,728
-3%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$1,693
$2,778
+64%
Investments
-
-
-
Property, Plant, & Equipment (net)
$1,266
$497
-61%
Other Assets
-
-
-
Total Assets
$138,491
$174,963
+26%
Liabilities
2023
2024
Change
Payables & Accruals
$2,376
$6,933
+192%
Grants Payable
-
-
-
Deferred Revenue
$0
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
-
-
-
Total Liabilities
$2,376
$6,933
+192%
Net assets
2023
2024
Change
Restricted Net Assets
$83,220
$90,490
+9%
Unrestricted Net Assets
$52,895
$77,540
+47%
Net assets
2023
2024
Change
Net assets
+$136,115
+$168,030
+23%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)